Research Catalog
Fibrinolytic and antithrombotic therapy : theory, practice, and management / Richard C. Becker.
- Title
- Fibrinolytic and antithrombotic therapy : theory, practice, and management / Richard C. Becker.
- Author
- Becker, Richard C.
- Publication
- New York : Oxford University Press, 2000.
Items in the Library & Off-site
Filter by
1 Item
Status | Format | Access | Call Number | Item Location |
---|---|---|---|---|
Text | Request in advance | RC694.3 .B39 2000 | Off-site |
Holdings
Details
- Description
- xii, 756 pages : illustrations; 18 cm
- Subject
- Anticoagulants > therapeutic use
- Blood Coagulation Disorders > physiopathology
- Cardiovascular Diseases > drug therapy
- Fibrinolytic Agents > therapeutic use
- Fibrinolytic agents
- Fibrinolytiques
- Myocardial Infarction > complications
- Myocardial Infarction > drug therapy
- Thrombolyse
- Thrombolytic Therapy
- Thrombolytic therapy
- Thrombose > Traitement
- Thrombosis > Treatment
- Bibliography (note)
- Includes bibliographical references and index.
- Contents
- 1. Historical Perspectives in Hemostasis, Thrombosis and Fibrinolysis: A Foundation for Understanding Thrombotic Disorders and Developing Effective Treatments -- 2. Vascular Biology and Thromboresistance -- 3. Fundamentals of Hematology -- 4. Inherited and Acquired Disorders of Blood Coagulation -- 5. The Biology and Biochemistry of Vascular Hemostasis and Pathologic Thrombosis -- 6. Arterial and Venous Thrombogenesis: Setting the Stage for Clinical Events -- 7. Experimental Models of Thrombosis, Fibrinolysis and Antithrombotics -- 8. Drug Development, Institutional Review Boards, and Trial Design -- 9. Mechanisms of Fibrinolysis -- 10. Fibrinolytic Agents -- 11. New Anticoagulants -- 12. Warfarin -- 13. Novel Platelet Antagonists -- 14. Platelet Glycoprotein IIb/IIIa Antagonists -- 15. Aspirin -- 16. Ticlopidine and Clopidogrel Pharmcology and Clinical Experience -- 17. The Open-Vessel Hypothesis: Importance of Rapid Diagnosis, Treatment and Reperfusion --
- 18. Fibrinolytic Therapy: Clinical Trials of Coronary Patency -- 19. Coronary Fibrinolysis and Ventricular Performance -- 20. Patient Treatment Delays and Prehospital Management Strategies: Human Behavior and Health Care Policy Perspectives -- 21. Evaluating Patients with Acute Chest Pain: Chest Pain Centers, Observation Units, and Clinical Decision Units -- 22. Acute Myocardial Infarction: Focus on Pathobiology, Diagnosis, and General Treatment -- 23. Current Approach to Myocardial Infarction and Its Management -- 24. Risk Stratification In Patients with Acute Myocardial Infarction -- 25. Management of Low-Risk Patients -- 26. Clinical Approach to High-Risk Patients -- 27. Noninvasive Assessment of Coronary Arterial Reperfusion -- 28. Recurrent Myocardial Ischemia Following Fibrinolytic Therapy -- 29. Fibrinolytic Retreatment -- 30. Defining Hemorrhagic Risk of Patients Treated with Fibrinolytic and Antithrombotic Agents --
- 31. Cardiac Rupture Following Acute Myocardial Infarction -- 32. Coronary Angiography: Timing and Clinical Indications -- 33. Coronary Angioplasty: Primary and Adjunctive Use -- 34. Laboratory Measurement of Thrombin Activity and Generation: Potential Roles in Determining Prognosis and Patient Management -- 35. A Comprehensive Approach to Unstable Angina and Non-ST Segment Elevation Myocardial Infarction -- 36. Pulmonary Embolism -- 37. Fibrinolytic and Adjunctive Therapy for Acute Ischemic Stroke -- 38. Antithrombotic Therapy in Cardiovascular, Peripheral Vascular, and Cerebrovascular Disease: A Summary of Prevention and Treatment Guidelines -- 39. General Approach to Coagulation Defects and Bleeding Disorders -- 40. Prothrombotic States and Thrombophilias -- 41. Heparin-Induced Thrombocytopenia -- 42. Coordinated Anticoagulation Clinics and Patient Self-Testing --
- App. A. Unfractionated Heparin Dosing During Percutaneous Coronary Interventions (PCI) with Platelet GPIIb/IIIa Antagonists -- App. B. Sheath Care for Patients Receiving Unfractionated Heparin and Platelet GPIIb/IIIa Antagonists During Percutaneous Coronary Interventions -- App. C. Antithrombotic and Fibrinolytic Agents -- App. D. Dosing Strategies for Catheterization and Percutaneous Coronary Interventions in Patients Receiving Low Molecular Weight Heparin.
- ISBN
- 019512331X
- LCCN
- 99032941
- Owning Institutions
- Columbia University Libraries